Ehave, Inc. — Cyborg Score 2/10

Challenged
Digital mental health platforms and AI-enabled healthcare software

Strategic Profile

The company offers MegaTeam and Ninja Reflex digital assessment software, the Ehave Dashboard mental health informatics platform using blockchain technology, and a platform for medical practitioners to deliver healthcare services to patients at home. Management is transitioning from digital therapeutics toward a broader AI-native technology strategy featuring AI Headhunter and early-stage AI BioLab and AI HealthOps platforms, none of which are yet generating revenue.

Cyborg Score Rationale

Ehave reported 2025 revenue from continuing operations of only $2,183 against a net loss of $3,756,479. Auditors included a going concern explanatory paragraph as the company expects continued losses and may not have sufficient resources to fund operations through the fourth quarter of 2026 without new capital. The company faces severe liquidity risk and execution challenges with pre-revenue AI platforms.

Top Insights

  • 2025 revenue from continuing operations was only $2,183 with accumulated deficit of $40.8 million
  • As of December 31, 2025, shareholders' deficit was $9.4 million with 1.48 billion common shares outstanding; going concern uncertainty exists through Q4 2026
  • Strategic pivot toward AI-native platforms (AI Headhunter, AI BioLab, AI HealthOps) from legacy digital therapeutics offerings
  • Current market capitalization is approximately $1.3 million

Named Competitors

  • Teladoc Platform — Leading virtual healthcare and mental health telemedicine platform
  • Ro Mental Health — Direct-to-consumer telehealth for mental health and chronic conditions
  • Akili Interactive — Digital therapeutics and prescription digital medicine platform
  • Mindstrong — AI-driven mental health assessment using smartphone behavioral signals

Recent Developments

  • (May 2026) Filed amended 2025 annual report disclosing going concern doubts and minimal revenue trajectory
  • (2025) Transitioned strategic focus from digital assessment games toward AI-enabled software platforms
  • (2025) MegaTeam ADHD and related digital therapeutics platforms remain in clinical validation with no commercial traction

Open the full interactive Ehave, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →